Navigation Links
Study Examines Current Approaches to Creating a Strategic Thought Leader Management System for Pharmaceutical Companies
Date:12/4/2015

CHAPEL HILL, N.C., Dec. 4, 2015 /PRNewswire/ -- As therapeutic areas become more crowded and payers more particular, the effectiveness of a pharmaceutical company's thought leader management system has never been more important.

The clinical and marketplace insights provided by Thought Leaders (TLs) can be the difference between a drug's success or its failure.

To create and maintain lasting and mutually beneficial relationships with thought leaders, organizations use systems, processes, and procedures to manage these important and complex relationships. The repercussions of an ineffective thought leader management system can be millions in wasted marketing or development costs for a life sciences company – not to mention the possibility of creating substantial compliance problems.

To probe current trends and future directions in integrated thought leader management, research and consulting leader Best Practices, LLC conducted a new benchmarking study, "Creating and Maintaining a Strategic KOL Management and Engagement System."

Topics addressed in the study include:

  • Reporting structure and oversight
  • Thought leader management roles and responsibilities
  • Thought leader interactions and management
  • Thought leader strategy and engagement

The study will help leaders involved in KOL management understand the current state of KOL management practices in the pharmaceutical industry, determine how TL management practices are evolving and identify innovative practices that are driving TL management success at other organizations. Study participants agreed that clinical research support (trials, IISs) and clinical advisory boards were the most important KOL services.

The report is based on data from 34 thought-leader management leaders from 29 biopharma and device organizations who participated in a field survey. Four high-level participants were interviewed to add qualitative depth to the study.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1397.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Morphotek Announces Collaboration Agreement With University Of Wisconsin-Madison To Study The Immunosuppressive Effects Of CA125 Tumor Antigen On Immune-Based Therapies For Ovarian Cancer
2. Eisai Presents Data on Perampanel and First and Largest U.S. Study on Caregiver Burden in Epilepsy at the 69th Annual American Epilepsy Society Meeting
3. Avanir Pharmaceuticals Announces Publication of Study Evaluating the Prevalence of Pseudobulbar Affect (PBA) Symptoms and Use of Antipsychotic Medications in Nursing Homes
4. Biovica and the International Breast Cancer Study Group & Breast International Group in Collaboration to Improve Outcome for Women with Breast Cancer
5. Samarbete för att förbättra behandling av bröstcancer mellan Biovica, International Breast Cancer Study Group & Breast International Group
6. New Study Examines How Pharmaceutical Industry Can Expedite Market Research Studies to More Quickly Uncover Insights
7. Burmans Specialty Pharmacy - a Diplomat Company - Collaborate in Landmark Study on Coverage of Hepatitis C Medications with Penn Medicine
8. NxThera Announces Publication of Rezum II 1-Year Clinical Study Data in Prestigious The Journal of Urology; Limited U.S. Commercial Launch of the Rezum System
9. Samumed Completes Phase II Study For Its Potential Treatment Of Androgenetic Alopecia: Safety Data Show No Serious Adverse Events In Any Treated Patient
10. Arsanis Initiates Phase 1 Study of Lead Product Candidate ASN100
11. PharmaEngine Announces the Lancet Publication of the ONIVYDE(TM) Phase 3 NAPOLI-1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... ... ... The Covid-19 pandemic has had an undeniable impact on the way we work. ... critical in the post-Covid world. , To help our partners get back to work ... a limited time only. , “We are literally putting our money where customers ...
(Date:6/19/2020)... RALEIGH, N.C. (PRWEB) , ... June 19, 2020 ... ... Evalueserve Global Recovery Index (EGRI) , a comprehensive recovery index that combines ... and social interactions. The index seeks to provide a holistic way of looking ...
(Date:6/19/2020)... YORK (PRWEB) , ... June 19, 2020 , ... The ... newsletter builds on the success of the company’s PODD: Partnership Opportunities in Drug Delivery ... , The newsletter is dedicated to highlighting different voices making an impact and ...
Breaking Medicine Technology:
(Date:6/23/2020)... ... ... The COVID-19 pandemic has set the stage for massive changes in healthcare delivery, ... predicts a sevenfold growth in telehealth services by 2025, indicating that people are ... , SPH Analytics , a leader in healthcare quality, experience analytics ...
(Date:6/23/2020)... ... 2020 , ... Advanced Kiosks , an industry-leading supplier of computer self-service ... demand for improved building access control resulting from the COVID-19 pandemic, Advanced Kiosks is ... to expand its products and services to meet the demands of their customers. Already ...
(Date:6/21/2020)... ... June 20, 2020 , ... BayMark Health Services ... (OTP) in Sun Valley, CA. Providing medication-assisted treatment (MAT) in the San Fernando ... provider of comprehensive treatment for opioid addiction in a professional and compassionate environment. ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... Gynecologic Laparoscopists), the premier organization in minimally invasive gynecologic surgery with membership ... nationwide trial of the AAGL’s Essentials in Minimally Invasive Gynecology (EMIG). The ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... and Vascular Center at AdventHealth Sebring. The 24,000 square foot facility will provide ... Heart and Vascular Center at AdventHealth Sebring will have 24 private lakefront rooms ...
Breaking Medicine News(10 mins):